Financials Safeguard Scientifics, Inc.
Equities
SFES
US7864493066
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8001 USD | -5.87% | -4.75% | +1.99% |
Mar. 26 | Safeguard Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 14 | Safeguard Scientifics, Inc.(OTCPK:SFES) dropped from S&P TMI Index | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 178 | 226.7 | 133.3 | 121.3 | 50.6 | 13 |
Enterprise Value (EV) 1 | 202.5 | 204.4 | 120.1 | 94.08 | 32.13 | 4.755 |
P/E ratio | -11.3 x | 4.16 x | -3.52 x | 5.4 x | -3.55 x | -1.29 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -16.5 x | -22.3 x | -16.3 x | - | - | - |
EV / FCF | -19.8 x | -15.4 x | -64.7 x | -21.7 x | -21.1 x | -4.4 x |
FCF Yield | -5.06% | -6.48% | -1.54% | -4.61% | -4.75% | -22.7% |
Price to Book | 2.66 x | 2.23 x | 2.12 x | 2.4 x | 1.44 x | 0.65 x |
Nbr of stocks (in thousands) | 20,647 | 20,645 | 20,893 | 16,506 | 16,322 | 16,576 |
Reference price 2 | 8.620 | 10.98 | 6.380 | 7.350 | 3.100 | 0.7845 |
Announcement Date | 3/1/19 | 2/28/20 | 3/5/21 | 3/11/22 | 3/10/23 | 3/26/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -12.28 | -9.174 | -7.358 | - | - | - |
EBIT 1 | -12.47 | -9.982 | -8.166 | -6.453 | -4.775 | -5.683 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -15.63 | 54.56 | -37.62 | 27 | -14.26 | -9.828 |
Net income 1 | -15.63 | 54.56 | -37.62 | 27 | -14.26 | -9.828 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.7608 | 2.640 | -1.813 | 1.360 | -0.8730 | -0.6100 |
Free Cash Flow 1 | -10.24 | -13.24 | -1.855 | -4.337 | -1.525 | -1.08 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/1/19 | 2/28/20 | 3/5/21 | 3/11/22 | 3/10/23 | 3/26/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 24.5 | - | - | - | - | - |
Net Cash position 1 | - | 22.2 | 13.2 | 27.2 | 18.5 | 8.25 |
Leverage (Debt/EBITDA) | -1.997 x | - | - | - | - | - |
Free Cash Flow 1 | -10.2 | -13.2 | -1.85 | -4.34 | -1.53 | -1.08 |
ROE (net income / shareholders' equity) | -21% | 64.7% | -45.7% | 47.6% | -33.5% | -36% |
ROA (Net income/ Total Assets) | -4.84% | -4.93% | -5.78% | -6.55% | -6.51% | -11.7% |
Assets 1 | 323 | -1,108 | 650.8 | -412 | 219.2 | 83.74 |
Book Value Per Share 2 | 3.240 | 4.930 | 3.010 | 3.060 | 2.150 | 1.200 |
Cash Flow per Share 2 | 0.3700 | 1.210 | 0.7500 | 1.500 | 0.8300 | 0.5700 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/1/19 | 2/28/20 | 3/5/21 | 3/11/22 | 3/10/23 | 3/26/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.99% | 13.38M | |
-6.03% | 113B | |
-3.98% | 87.91B | |
+20.96% | 63.76B | |
+5.29% | 61.9B | |
+10.12% | 42.86B | |
+7.95% | 40.84B | |
+18.92% | 34.58B | |
+5.88% | 25.48B | |
-5.25% | 22.13B |
- Stock Market
- Equities
- SFES Stock
- Financials Safeguard Scientifics, Inc.